{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:14:48Z","timestamp":1792034088936,"version":"4.4.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejim.2018.01.004","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T11:07:44Z","timestamp":1515064064000},"page":"12-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":552,"special_numbering":"C","title":["Practical considerations in medical cannabis administration and dosing"],"prefix":"10.1016","volume":"49","author":[{"given":"Caroline A.","family":"MacCallum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan B.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2018.01.004_bb0005","series-title":"Handbook of cannabinoids","first-page":"23","article-title":"The pharmacological history of Cannabis","author":"Russo","year":"2014"},{"key":"10.1016\/j.ejim.2018.01.004_bb0010","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1002\/cbdv.200790144","article-title":"History of cannabis and its preparations in saga, science and sobriquet","volume":"4","author":"Russo","year":"2007","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.ejim.2018.01.004_bb0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ejim.2018.01.004_bb0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drugalcdep.2017.08.010","article-title":"Physicians-in-training are not prepared to prescribe medical marijuana","volume":"180","author":"Evanoff","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ejim.2018.01.004_bb0025","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMra1614394","article-title":"Evidence for health decision making - beyond randomized, controlled trials","volume":"377","author":"Frieden","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.01.004_bb0030","series-title":"Cannabis inflorescence: Cannabis spp.: standards of identity, analysis and quality control","author":"Upton","year":"2013"},{"key":"10.1016\/j.ejim.2018.01.004_bb0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3389\/fphar.2016.00309","article-title":"Current therapeutic cannabis controversies and clinical trial design issues","volume":"7","author":"Russo","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ejim.2018.01.004_bb0040","first-page":"71","article-title":"Cannabis pharmacology: the usual suspects and a few promising leads","volume":"80","author":"Russo","year":"2017","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.ejim.2018.01.004_bb0045","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-2236(98)01283-1","article-title":"Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action","volume":"21","author":"Di Marzo","year":"1998","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.ejim.2018.01.004_bb0050","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ejim.2018.01.004_bb0055","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ejim.2018.01.004_bb0060","article-title":"Pharmacological foundations of Cannabis chemovars: no \u201cstrain\u201d, no gain","author":"Lewis","year":"2017","journal-title":"Planta Med"},{"key":"10.1016\/j.ejim.2018.01.004_bb0065","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1556-4029.2007.00603.x","article-title":"Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology","volume":"53","author":"Potter","year":"2008","journal-title":"J Forensic Sci"},{"issue":"5","key":"10.1016\/j.ejim.2018.01.004_bb0070","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1556-4029.2010.01441.x","article-title":"Potency trends of delta(9)-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008","volume":"55","author":"Mehmedic","year":"2010","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.ejim.2018.01.004_bb0075","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.intimp.2005.10.002","article-title":"Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways","volume":"6","author":"Verhoeckx","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ejim.2018.01.004_bb0080","series-title":"Handbook of cannabis","first-page":"435","article-title":"Effects of phytocannabinoids on nausea and vomiting","author":"Rock","year":"2014"},{"issue":"23","key":"10.1016\/j.ejim.2018.01.004_bb0085","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1111\/bph.14019","article-title":"Tetrahydrocannabinolic acid is a potent PPARgamma agonist with neuroprotective activity","volume":"174","author":"Nadal","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ejim.2018.01.004_bb0090","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.yebeh.2016.12.032","article-title":"The current status of artisanal Cannabis for the treatment of epilepsy in the United States","volume":"70","author":"Sulak","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ejim.2018.01.004_bb0095","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/bph.12043","article-title":"Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation","volume":"168","author":"Bolognini","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ejim.2018.01.004_bb0100","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s00213-017-4626-5","article-title":"Effect of prior foot shock stress and Delta9-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats","volume":"234","author":"Rock","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejim.2018.01.004_bb0105","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.ejim.2018.01.004_bb0110","series-title":"Comprehensive treatment of chronic pain by medical, interventional and behavioral approaches","first-page":"181","article-title":"Role of cannabinoids in pain management","author":"Russo","year":"2013"},{"key":"10.1016\/j.ejim.2018.01.004_bb0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1513\/AnnalsATS.201212-127FR","article-title":"Effects of marijuana smoking on the lung","volume":"10","author":"Tashkin","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ejim.2018.01.004_bb0120","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/sj.clpt.6100200","article-title":"Vaporization as a smokeless cannabis delivery system: a pilot study","volume":"82","author":"Abrams","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ejim.2018.01.004_bb0125","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1111\/j.1360-0443.2008.02281.x","article-title":"Ammonia release from heated \u2018street\u2019 cannabis leaf and its potential toxic effects on cannabis users","volume":"103","author":"Bloor","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.ejim.2018.01.004_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-7517-4-11","article-title":"Decreased respiratory symptoms in cannabis users who vaporize","volume":"4","author":"Earleywine","year":"2007","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.ejim.2018.01.004_bb0135","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.addbeh.2014.05.013","article-title":"New method of cannabis ingestion: the dangers of dabs?","volume":"39","author":"Loflin","year":"2014","journal-title":"Addict Behav"},{"key":"10.1016\/j.ejim.2018.01.004_bb0140","series-title":"Committee on the health effects of marijuana: an evidence review and research agenda. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research","first-page":"1","author":"National Academies of Sciences Engineering and Medicine (U.S.)","year":"2017"},{"key":"10.1016\/j.ejim.2018.01.004_bb0145","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.01.004_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.ejim.2018.01.004_bb0155","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.psyneuen.2013.08.004","article-title":"Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks","volume":"38","author":"Hill","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ejim.2018.01.004_bb0160","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.0.CO;2-D","article-title":"Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease","volume":"12","author":"Volicer","year":"1997","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.ejim.2018.01.004_bb0165","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejim.2018.01.004_bb0170","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jpain.2015.07.014","article-title":"Cannabis for the management of pain: assessment of safety study (COMPASS)","volume":"16","author":"Ware","year":"2015","journal-title":"J Pain"},{"key":"10.1016\/j.ejim.2018.01.004_bb0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1300\/J175v02n01_02","article-title":"Chronic cannabis use in the compassionate investigational new drug program: an examination of benefits and adverse effects of legal clinical cannabis","volume":"2","author":"Russo","year":"2002","journal-title":"J Cannabis Ther"},{"key":"10.1016\/j.ejim.2018.01.004_bb0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1300\/J175v02n03_02","article-title":"Cannabis treatments in obstetrics and gynecology: a historical review","volume":"2","author":"Russo","year":"2002","journal-title":"J Cannabis Ther"},{"key":"10.1016\/j.ejim.2018.01.004_bb0185","article-title":"Cannabis use during pregnancy: pharmacokinetics and effects on child development","author":"Grant","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ejim.2018.01.004_bb0190","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/AOG.0000000000001649","article-title":"Maternal marijuana use and adverse neonatal outcomes: a systematic review and meta-analysis","volume":"128","author":"Conner","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejim.2018.01.004_bb0195","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cpdd.36","article-title":"A multiple-dose, randomized, double-blind, placebo-controlled, parallel-group QT\/QTc study to evaluate the electrophysiologic effects of THC\/CBD spray","volume":"2","author":"Sellers","year":"2013","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.ejim.2018.01.004_bb0200","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejim.2018.01.004_bb0205","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1503\/cmaj.071178","article-title":"Adverse effects of medical cannabinoids: a systematic review","volume":"178","author":"Wang","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.ejim.2018.01.004_bb0210","series-title":"Sativex safety profile is improving over time. 21st Annual Symposium on the Cannabinoids","first-page":"GW1","author":"Russo","year":"2011"},{"key":"10.1016\/j.ejim.2018.01.004_bb0215","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1468-1331.2010.03328.x","article-title":"A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex((R))), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis","volume":"18","author":"Novotna","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ejim.2018.01.004_bb0220","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-244X-5-17","article-title":"Two cases of \u201ccannabis acute psychosis\u201d following the administration of oral cannabis","volume":"5","author":"Favrat","year":"2005","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.ejim.2018.01.004_bb0225","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1389200217666151210142051","article-title":"Cannabinoids and cytochrome P450 interactions","volume":"17","author":"Zendulka","year":"2016","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.ejim.2018.01.004_bb0230","series-title":"Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of rifampicin, ketoconazole, and omeprazole on the pharmacokinetics of THC\/CBD oromucosal spray in healthy volunteers","first-page":"236","volume":"2","author":"Stott","year":"2013"},{"key":"10.1016\/j.ejim.2018.01.004_bb0235","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1089\/can.2015.0012","article-title":"Human metabolites of cannabidiol: a review on their formation, biological activity, and relevance in therapy","volume":"1","author":"Ujvary","year":"2016","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.ejim.2018.01.004_bb0240","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/1352458505070618","article-title":"Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis","volume":"12","author":"Wade","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.ejim.2018.01.004_bb0245","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1352458511419700","article-title":"A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex(R) (nabiximols)","volume":"18","author":"Notcutt","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.ejim.2018.01.004_bb0250","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00415-012-6634-z","article-title":"Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis","volume":"260","author":"Serpell","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.ejim.2018.01.004_bb0255","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.yebeh.2016.09.040","article-title":"Cannabis and epilepsy: an ancient treatment returns to the fore","volume":"70","author":"Russo","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ejim.2018.01.004_bb0260","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejim.2018.01.004_bb0265","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/cbdv.200790150","article-title":"Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine","volume":"4","author":"Russo","year":"2007","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.ejim.2018.01.004_bb0270","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","article-title":"Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain","volume":"39","author":"Johnson","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ejim.2018.01.004_bb0275","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jpain.2012.01.003","article-title":"Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial","volume":"13","author":"Portenoy","year":"2012","journal-title":"J Pain"},{"key":"10.1016\/j.ejim.2018.01.004_bb0280","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.bjc.6603236","article-title":"A pilot clinical study of delta(9)-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme","volume":"95","author":"Guzman","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejim.2018.01.004_bb0285","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00381-011-1410-4","article-title":"Spontaneous regression of septum pellucidum\/forniceal pilocytic astrocytomas\u2013possible role of Cannabis inhalation","volume":"27","author":"Foroughi","year":"2011","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.ejim.2018.01.004_bb0290","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1159\/000356446","article-title":"Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia chromosome mutation","volume":"6","author":"Singh","year":"2013","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.ejim.2018.01.004_bb0295","series-title":"GW pharmaceuticals achieves positive results in phase 2 proof of concept study in glioma","author":"GW Pharmaceuticals","year":"2017"},{"key":"10.1016\/j.ejim.2018.01.004_bb0300","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1535-7163.MCT-10-0688","article-title":"A combined preclinical therapy of cannabinoids and temozolomide against glioma","volume":"10","author":"Torres","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ejim.2018.01.004_bb0305","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1476-4598-9-196","article-title":"Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition","volume":"9","author":"Caffarel","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ejim.2018.01.004_bb0310","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/00000542-200605000-00021","article-title":"A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) for postoperative pain management","volume":"104","author":"Holdcroft","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejim.2018.01.004_bb0315","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and (\u2212)delta9-tetrahydrocannabinol are neuroprotective antioxidants","volume":"95","author":"Hampson","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejim.2018.01.004_bb0320","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1476-5381.2011.01365.x","article-title":"Prospects for cannabinoid therapies in basal ganglia disorders","volume":"163","author":"Fernandez-Ruiz","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ejim.2018.01.004_bb0325","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/mds.20111","article-title":"Survey on cannabis use in Parkinson's disease: subjective improvement of motor symptoms","volume":"19","author":"Venderova","year":"2004","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.ejim.2018.01.004_bb0330","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1818","article-title":"Medical cannabinoids in children and adolescents: a systematic review","volume":"140","author":"Wong","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejim.2018.01.004_bb0335","article-title":"On the application of cannabis in paediatrics and epileptology","volume":"25","author":"Lorenz","year":"2004","journal-title":"Neuroendocrinol Lett"},{"key":"10.1016\/j.ejim.2018.01.004_bb0340","series-title":"Cannbinoide bei Kindern. Gute Erfahrungen bei Schmerzen, Spastik und in der Onkologie. Angewandte Schmerztherapie und Palliativmedizin","first-page":"55","author":"Gottschling","year":"2011"},{"key":"10.1016\/j.ejim.2018.01.004_bb0345","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/0024-3205(95)00194-B","article-title":"An efficient new cannabinoid antiemetic in pediatric oncology","volume":"56","author":"Abrahamov","year":"1995","journal-title":"Life Sci"},{"key":"10.1016\/j.ejim.2018.01.004_bb0350","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1586\/14737175.8.7.1037","article-title":"Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia","volume":"8","author":"Muller-Vahl","year":"2008","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.ejim.2018.01.004_bb0355","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.2174\/13816128113199990427","article-title":"Cannabinoids and schizophrenia: therapeutic prospects","volume":"20","author":"Robson","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ejim.2018.01.004_bb0360","series-title":"Handbook of psychotropic herbs: A scientific analysis of herbal remedies for psychiatric conditions","author":"Russo","year":"2001"},{"key":"10.1016\/j.ejim.2018.01.004_bb0365","series-title":"Weiner's pain management: a practical guide for clinicians","first-page":"823","article-title":"The role of cannabis and cannabinoids in pain management","author":"Russo","year":"2006"},{"key":"10.1016\/j.ejim.2018.01.004_bb0370","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.lfs.2003.09.038","article-title":"Synergistic interactions between cannabinoid and opioid analgesics","volume":"74","author":"Cichewicz","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.ejim.2018.01.004_bb0375","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugpo.2017.01.011","article-title":"Medical cannabis access, use, and substitution for prescription opioids and other substances: a survey of authorized medical cannabis patients","volume":"42","author":"Lucas","year":"2017","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.ejim.2018.01.004_bb0380","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1477-7517-6-35","article-title":"Cannabis as a substitute for alcohol and other drugs","volume":"6","author":"Reiman","year":"2009","journal-title":"Harm Reduct J"},{"issue":"12","key":"10.1016\/j.ejim.2018.01.004_bb0385","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/AJP.0000000000000364","article-title":"The effect of medicinal cannabis on pain and quality of life outcomes in chronic pain: a prospective open-label study","volume":"32","author":"Haroutounian","year":"2016","journal-title":"Clin J Pain"},{"key":"10.1016\/j.ejim.2018.01.004_bb0390","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jamainternmed.2014.4005","article-title":"Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999\u20132010","volume":"174","author":"Bachhuber","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ejim.2018.01.004_bb0395","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1377\/hlthaff.2015.1661","article-title":"Medical marijuana laws reduce prescription medication use in Medicare part D","volume":"35","author":"Bradford","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.ejim.2018.01.004_bb0400","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1377\/hlthaff.2016.1135","article-title":"Medical marijuana laws may be associated with a decline in the number of prescriptions for Medicaid enrollees","volume":"36","author":"Bradford","year":"2017","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.ejim.2018.01.004_bb0405","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpainsymman.2012.07.014","article-title":"An open-label extension study to investigate the long-term safety and tolerability of THC\/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics","volume":"46","author":"Johnson","year":"2013","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ejim.2018.01.004_bb0410","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/clpt.2011.188","article-title":"Cannabinoid-opioid interaction in chronic pain","volume":"90","author":"Abrams","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.ejim.2018.01.004_bb0415","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000357742","article-title":"CBD spray and MS spasticity symptoms: data from latest studies","volume":"71","author":"Rekand","year":"2014","journal-title":"Eur Neurol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620518300049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620518300049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T18:50:34Z","timestamp":1535136634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620518300049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":83,"alternative-id":["S0953620518300049"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2018.01.004","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practical considerations in medical cannabis administration and dosing","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2018.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}